Association of Transthyretin Valine to Isoleucine Variant with Kidney Outcomes in Community-Dwelling Black Adults
Open Access
- 29 July 2025
- journal article
- Published by Wolters Kluwer Health in Kidney360
- Vol. 6 (12) , 2248-2250
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (U01 NS041588)
- National Institute of Neurological Disorders and Stroke (U01 NS041588)
This publication has 7 references indexed in Scilit:
- Hereditary transthyretin amyloidosis: a comprehensive review with a focus on peripheral neuropathyFrontiers in Neurology, 2023
- Kidney involvement in hereditary transthyretin amyloidosis: a cohort study of 103 patientsClinical Kidney Journal, 2022
- Association of Transthyretin Val122Ile Variant With Incident Heart Failure Among Black IndividualsJAMA, 2022
- New Creatinine- and Cystatin C–Based Equations to Estimate GFR without RaceNew England Journal of Medicine, 2021
- Hereditary transthyretin amyloidosis overviewNeurological Sciences, 2020
- Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino AncestryJAMA, 2019
- Variant-Sequence Transthyretin (Isoleucine 122) in Late-Onset Cardiac Amyloidosis in Black AmericansNew England Journal of Medicine, 1997